Bright Green Spending $250M on NM Pharma Plant Facility

Bright Green Corporation signed an agreement with Dalsem Greenhouse Technologies BV for a $250 million construction project to expand the Company’s current research, production and extraction processing facility located in rural Grants, New Mexico. Bright Green is a licensed manufacturer of plant-based drugs and Active Pharmaceutical Ingredients (APIs) in the U.S.

The proposed expansion will add 7 million square feet of manufacturing and production capabilities. The Dalsem Agreement provides that Dalsem will construct the additional facility to its specifications and build them in a modular fashion. In addition, the facility will be powered by a 100-plus-megawatt solar field the company plans to build.

This expansion is a direct result of Bright Green obtaining the regulatory approvals for the production of Schedule I and II controlled substances from the DEA and the State of New Mexico Board of Pharmacy. The expansion will facilitate the production and manufacturing required to process the active pharmaceutical ingredients (“API”) and to make generic prescription drugs.